Ronil A. Patel - Dec 1, 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role: Chief Business Officer
Signature: /s/ Stephanie Swan, by Power of Attorney
Stock symbol: OCUP
Transactions as of: Dec 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/5/2023, 04:30 PM
Previous filing: Apr 26, 2023
Next filing: Jan 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+49.7K	+117.46%	$0.00	92K	Dec 1, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+74.5K		$0.00	74.5K	Dec 1, 2023	Common Stock	74.5K	$2.99	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.
F2	The option will vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.